Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New Perspectives

Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, with poor survival in both treated and untreated patients. Recent studies began to explain the molecular pathway, comprising the dynamic structural and mechanical changes involved in GBM. In this cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsi, Lorenzo, Mescola, Andrea, Alessandrini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479730/
https://www.ncbi.nlm.nih.gov/pubmed/30978987
http://dx.doi.org/10.3390/ijms20071796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479730/
https://www.ncbi.nlm.nih.gov/pubmed/30978987
http://dx.doi.org/10.3390/ijms20071796

Ejemplares similares